2017
DOI: 10.2174/1567205014666170417113834
|View full text |Cite
|
Sign up to set email alerts
|

Cognitive Mechanisms in Decision-Making in Patients With Mild Alzheimer Disease

Abstract: That problems in our patients' decision-making could be due to the characteristic memory deficits of this disease, which prevents them from establishing new stimulus-reward relationships and eliminating previously learned responses as a result of the parietal and temporal atrophy they present.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
7
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 0 publications
3
7
0
Order By: Relevance
“…The number of his disadvantageous choices on deck A and B surpassed his advantageous choice on deck C and D close to 2.5-fold. This result further supports that he has risky behavior in decision making [ 13 14 ].…”
Section: Case Reportssupporting
confidence: 70%
“…The number of his disadvantageous choices on deck A and B surpassed his advantageous choice on deck C and D close to 2.5-fold. This result further supports that he has risky behavior in decision making [ 13 14 ].…”
Section: Case Reportssupporting
confidence: 70%
“…This finding suggests that the healthy controls assessed the advantageous decks more favorably than the disadvantageous decks and learned to decide advantageously by utilizing feedback and modifying their strategy over time, but the patients with AD and MCI did not. The response patterns of the two groups of clinical patients may be attributed to deficits in memory and executive function, which prevents them from establishing new stimulus-reward relationships and eliminating previously learned responses due to the parietal and temporal atrophy they present (44). Another possible explanation of these results is a dysfunctional ventromedial prefrontal cortex (VMPC) in patients with AD (45)(46)(47) and MCI (48).…”
Section: Discussionmentioning
confidence: 99%
“…This should have been made prospectively to be sure that they did not present, at the time of their inclusion, a neurocognitive pathology at an infra-clinical stage. Indeed, neurodegenerative pathologies impact decision-making capacities [62][63][64][65]. Nevertheless, it appears that tests focused on decision-making processes can remain informative even in the mild stages of these diseases, and the impact of mild pathological cases on overall results is limited, as shown in Jacus et al [66].…”
Section: Discussionmentioning
confidence: 99%